Literature DB >> 2264477

Incidence and prevalence of coeliac disease in Tampere. Coeliac disease is not disappearing.

M Mäki1, K Holm.   

Abstract

Entities:  

Mesh：

Year:  1990        PMID： 2264477     DOI： 10.1111/j.1651-2227.1990.tb11367.x

Source DB:  PubMed          Journal:  Acta Paediatr Scand        ISSN： 0001-656X


× No keyword cloud information.
  7 in total

1.  Estimating the incidence of coeliac disease with capture-recapture methods within four geographic areas in Italy.

Authors:  G Corrao; P Usai; G Galatola; N Ansaldi; A Meini; M A Pelli; G Castellucci; G R Corazza
Journal:  J Epidemiol Community Health       Date:  1996-06       Impact factor: 3.710

2.  Increase in gamma/delta T cell receptor bearing lymphocytes in normal small bowel mucosa in latent coeliac disease.

Authors:  M Mäki; K Holm; P Collin; E Savilahti
Journal:  Gut       Date:  1991-11       Impact factor: 23.059

3.  Influence of infant feeding and gluten intake on coeliac disease.

Authors:  H Ascher; I Krantz; L Rydberg; P Nordin; B Kristiansson
Journal:  Arch Dis Child       Date:  1997-02       Impact factor: 3.791

4.  Different features of coeliac disease in two neighbouring countries.

Authors:  H Ascher; K Holm; B Kristiansson; M Mäki
Journal:  Arch Dis Child       Date:  1993-09       Impact factor: 3.791

5.  Intestinal permeability in patients with coeliac disease and relatives of patients with coeliac disease.

Authors:  R M van Elburg; J J Uil; C J Mulder; H S Heymans
Journal:  Gut       Date:  1993-03       Impact factor: 23.059

6.  Prevalence of celiac disease in Iranian children with idiopathic short stature.

Authors:  Jalal Hashemi; Eskandar Hajiani; H-Bb Shahbazin; Rahim Masjedizadeh; Navab Ghasemi
Journal:  World J Gastroenterol       Date:  2008-12-28       Impact factor: 5.742

7.  The Swedish coeliac disease epidemic with a prevailing twofold higher risk in girls compared to boys may reflect gender specific risk factors.

Authors:  Anneli Ivarsson; Lars Ake Persson; Lennarth Nyström; Olle Hernell
Journal:  Eur J Epidemiol       Date:  2003       Impact factor: 8.082
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.